Why the study?
The study was conducted to investigate blood pressure trajectories and the impact of pharmacological intervention in children with chronic kidney disease.
Does intensification of antihypertensive treatment improve blood pressure trajectories in children with chronic kidney disease?
Cohort (n=320)
Yes
Does intensification of antihypertensive treatment improve blood pressure trajectories in children with chronic kidney disease?
In children with CKD, intensification of antihypertensive therapy significantly improves blood pressure control, though a notable proportion of previously normotensive patients develop de novo hypertension over time.
Answers are grounded in this paper and cite their sources.
Supports intensified BP management in pediatric CKD; leaves open effects on progression or CV events.
Rationale To investigate blood pressure (BP) trajectories, and the impact of pharmacological intervention in children with chronic kidney disease (CKD). Methods Analysis of antihypertensive treatment (AHT) and BP slopes in 320 patients of the 4C Study cohort with CKD prior to renal replacement therapy, based on a minimum of three individual observations and two years of follow-up. Results At enrollment, 70 patients (22%) had uncontrolled or untreated hypertension, 130 patients (41%) had controlled hypertension, and 120 patients (37%) had normotension without antihypertensive treatment. AHT medication was prescribed in 53% of patients at baseline and initiated or added in 91 patients (AHT-I, 28%) during follow-up. Overall BP standard deviation score (SDS) remained stable over time in the cohort (ß= -0.037±0.034, p=0.34 and -0.029± 0.348, p=0.093 per year for systolic and diastolic BP SDS). In the AHT-I group, systolic and diastolic BP SDS was higher at baseline and decreased significantly during follow-up (−0.22±0.07, p<.003 and -0.12±0.05 SDS per year, p=0.01). Only 8/70 (11%) patients of the previously untreated/uncontrolled group remained untreated at the last observation, while 31 (44%) were controlled during follow-up. Of the 120 normotensive patients at baseline, 60% remained normotensive while 40% progressed to uncontrolled/untreated (n=23, 19%) or controlled (n=24, 20%) hypertension. Conclusions The study provides comprehensive real-world evidence on long-term management of blood pressure in children with CKD from the 4C Study. Although blood pressure control improved significantly with the intensification of antihypertensive therapy, a notable proportion of previously normotensive patients developed de novo hypertension over the observation period.
No takes yet. Share an insight, caveat, or question.
Doyon et al. (2024) conducted a cohort in Chronic kidney disease (CKD) (n=320). Intensification of antihypertensive treatment vs. No intensification of antihypertensive treatment was evaluated on Change in systolic blood pressure standard deviation score (SDS) per year (95% CI -0.36 - -0.07, p=0.003).
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: